A rating of 71 puts Rhythm Pharmaceuticals Inc (RYTM) near the top of the Biotechnology industry according to InvestorsObserver. Rhythm Pharmaceuticals Inc's score of 71 means it scores higher than 71% of stocks in the industry. Rhythm Pharmaceuticals Inc also received an overall rating of 63, putting it above 63% of all stocks. Biotechnology is ranked 15 out of the 148 industries.
RYTM has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on RYTM!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 63 means the stock is more attractive than 63 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Rhythm Pharmaceuticals Inc Stock Today?
Rhythm Pharmaceuticals Inc (RYTM) stock has gained 2.83% while the S&P 500 has fallen -0.16% as of 11:52 AM on Friday, Mar 8. RYTM is higher by $1.18 from the previous closing price of $41.67 on volume of 84,256 shares. Over the past year the S&P 500 is up 31.41% while RYTM is higher by 104.44%. RYTM lost -$3.20 per share the over the last 12 months.
Click Here to get the full Stock Report for Rhythm Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
